French Innovative Leukemia Organisation   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Tours France (2015)

Organization Overview

First Clinical Trial
2015
NCT00483132
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

FILO (French Innovative Leukemia Organization) | French Innovative Leukemia Organisation | French Innovative Leukemia Organization | French Innovative Leukemia Organization (FILO)